Two-dimensional electrophoresis analysis of differential protein expression in squamous carcinoma of the cervix

Chinese Journal of Cancer Research

Volumn 20, Issue 3, 2008, Pages 164-170

  Zhu, Xue Qiong ^a   Wu, Jie Li ^a   Yu, Li Rong ^a   Lin, Yi ^a   Lü, Jie Qiang ^a   Zou, Shuang Wei ^a   Hu, Yue ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Differential expression; Proteome; Two dimensional gel electrophoresis

Indexed keywords

CELL ENZYME; STRUCTURAL PROTEIN; TUMOR MARKER;

ADULT; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; REPRODUCIBILITY; SILVER STAINING; TWO DIMENSIONAL ELECTROPHORESIS; UTERINE CERVIX CARCINOMA;

EID: 52949132576     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-008-0164-3     Document Type: Article

References (18)

1. Tiltman AJ. The pathology of cervical tumours [J]. Best Pract Res Clin Obstet Gynaecol. 2005; 19: 485-500.
2. Hakim AA, Lin PS, Wilczynski S, et al. Indications and efficacy of the human papillomavirus vaccine [J]. Curr Treat Options Oncol 2007; 8:393-401.
3. Llorca J, Rodriguez-Cundin P, Dierssen-Sotos T, et al. Cervical cancer mortality is increasing in Spanish women younger than 50 [J]. Cancer Lett 2006; 240:36-40.
4. Warwood S, Mohammed S, Cristea IM, et al. Guanidination chemistry for qualitative and quantitative proteomics [J]. Rapid Commun Mass Spectrom 2006; 20:3245-56.
5. Görg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics [J]. Proteomics 2004; 4:3665-85.
6. Issaq HJ, Veenstra TD. The role of electrophoresis in disease biomarker discovery [J]. Electrophoresis 2007; 28:1980-8.
7. Fenyö D, Beavis RC. Informatics development: challenges and solutions for MALDI mass spectrometry [J]. Mass Spectrom Rev 2008; 27: 1-19.
8. van der Merwe DE, Oikonomopoulou K, Marshall J, et al. Mass spectrometry: uncovering the cancer proteome for diagnostics [J]. Adv Cancer Res 2007; 96:23-50.
9. Yan JX, Wait R, Berkelman T, et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry [J]. Electrophoresis 2000, 21:3666-72.
10. Fung ET, Weinberger SR, Gavin E, et al. Bioinformatics approaches in clinical proteomics [J]. Expert Rev Proteomics 2005; 2:847-62.
11. Laronga C, Drake RR. Proteomic approach to breast cancer [J]. Cancer Control 2007; 14:360-8.
12. Boyce EA, Kohn EC. Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets [J]. Int J Gynecol Cancer 2005; 15 Suppl 3:266-73.
13. Massion PP, Caprioli RM. Proteomic strategies for the characterization and the early detection of lung cancer [J]. J Thorac Oncol 2006; 1: 1027-39.
14. López JL. Two-dimensional electrophoresis in proteome expression analysis [J]. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 849: 190-202.
15. Mikami S, Kishimoto T, Hori H, et al. Technical improvement to 2D-PAGE of rice organelle membrane proteins [J]. Biosci Biotechnol Biochem 2002; 66:1170-3.
16. Zehbe I, Schmidt M, Maeurer M, et al. Different T-cell Receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions [J]. Zentralbl Gynakol 2006; 128:266-70.
17. Ferrandina G, Ranelletti FO, Legge F, et al. Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer [J]. Clin Cancer Res 2006; 12:2055-60.
18. Watson MB, Lind MJ, Smith L, et al. Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model [J]. Acta Oncol2007; 46:651-8.